Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy

Bioorganic & Medicinal Chemistry
Jie HeHuihui Zeng

Abstract

Thioredoxin reductase (TrxR) is critical for cellular redox regulation and is involved in tumor proliferation, apoptosis and metastasis. Its C-terminal redox-active center contains a cysteine (Cys497) and a unique selenocysteine (Sec498), which are exposed to solvent and easily accessible. Thus, it is becoming an important target for anticancer drugs. Selective inhibition of TrxR by 1,2-(bis-1,2-benzisoselenazol-3(2H)-one)ethane (4a) prevents proliferation of several cancer cell lines both in vivo and in vitro. Using the structure of 4a as a starting point, a series of novel bis-1,2-benzisoselenazol-3(2H)-ones was designed, prepared and tested to explore the structure-activity relationships (SARs) for this class of inhibitor and to improve their potency. Notably, 1,2-(5,5'-dimethoxybis(1,2-benzisoselenazol-3(2H)-one))ethane (12) was found to be more potent than 4a in both in vitro and in vivo evaluation. Its binding sites were confirmed by biotin-conjugated iodoacetamide assay and a SAR model was generated to guide further structural modification.

References

Aug 12, 2003·Proteins·Marcel L VerdonkRichard D Taylor
May 14, 2005·Antioxidants & Redox Signaling·Hajime Nakamura
Sep 16, 2006·Chembiochem : a European Journal of Chemical Biology·Stephan GromerWolfgang Brandt
Nov 23, 2006·Antioxidants & Redox Signaling·Christopher Horst Lillig, Arne Holmgren

❮ Previous
Next ❯

Citations

Mar 18, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Wei ChenXiangming Guan
Jul 12, 2016·Pharmaceuticals·Jim KüppersMichael Gütschow
Jun 13, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mirosław GiurgMagdalena Piętka-Ottlik
Apr 26, 2016·Dalton Transactions : an International Journal of Inorganic Chemistry·Yuan-Yuan ZhangChun-Lin Ma
Apr 30, 2019·International Journal of Molecular Sciences·Izabella JastrzebskaClaudio Santi
Oct 3, 2014·Chemical & Pharmaceutical Bulletin·Yikai ZhangXueyun Zhong
Dec 24, 2019·Essays in Biochemistry·Elias S J Arnér
Dec 19, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jun LuArne Holmgren
Nov 11, 2020·Chembiochem : a European Journal of Chemical Biology·Jennie O'LoughlinMarina Rubini
May 22, 2021·Molecular Informatics·Pablo Andrei NogaraJoão Batista Teixeira Rocha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis